Ikigai Ventures Ltd
LSE:IKIV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/S
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.
Valuation Scenarios
If P/S returns to its 3-Year Average (981.2), the stock would be worth GBX17.56 (58% downside from current price).
| Scenario | P/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 2 347.5 | GBX42 |
0%
|
| 3-Year Average | 981.2 | GBX17.56 |
-58%
|
| 5-Year Average | 981.2 | GBX17.56 |
-58%
|
| Industry Average | 0.1 | GBX0 |
-100%
|
| Country Average | 0.1 | GBX0 |
-100%
|
Forward P/S
Today’s price vs future revenue
Peer Comparison
| Market Cap | P/S | P/E | ||||
|---|---|---|---|---|---|---|
| GG |
I
|
Ikigai Ventures Ltd
LSE:IKIV
|
8.7m GBP | 2 347.5 | -12.6 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
291.1B USD | 0 | 0 | |
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR | 0 | 0 | |
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD | 351.6 | 4 020.7 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
100.2B ZAR | 5.5 | 10.4 | |
| US |
F
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
67.4B USD | 0 | 38 074.9 | |
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
56B USD | 0 | 0 | |
| CH |
G
|
Galderma Group AG
SIX:GALD
|
38.4B CHF | 0 | 0 | |
| US |
|
Coupang Inc
F:788
|
31.4B EUR | 1 | 173.5 | |
| US |
|
Symbotic Inc
NASDAQ:SYM
|
35.6B USD | 14.8 | -3 268.5 | |
| ZA |
V
|
Vukile Property Fund Ltd
JSE:VKE
|
29.7B ZAR | 5.6 | 6.9 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0 |
| Median | 0.1 |
| 70th Percentile | 2 |
| Max | 60 |
Other Multiples
Ikigai Ventures Ltd
Glance View
Ikigai Ventures Ltd. operates as a special purpose acquisition company. The firm focuses on acquiring businesses focused on having a social impact. Acquisitions will be funded through a combination of cash, equity, and debt, as required. There is no restriction as to the geographical location of any target business. This may comprise the acquisition of a single company or business or a series of acquisitions by way of a roll-up strategy, whereby Ikigai acquires and merges several businesses in a particular sector. The firm has not commenced any operations nor generated any revenues.
